Bizu Gelaye

Has grant

Chief, Epidemiology Branch and Senior Investigator

Eunice Kennedy Shriver National Institute of Child Health and Human Development
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Maternal hair cortisol concentrations, prenatal psychopathology and offspring behavioral phenotypes

Open Date: 2022-07-01

Close Date: 2024-06-30

Grant: Close

Intergenerational impact of maternal trauma history on preschoolers' behavioral health outcomes: Assessing links with caregiving sensitivity and DNA methylation

Open Date: 2020-09-08

Close Date: 2025-08-31

Grant: Close

The Role of Hypothalamic Pituitary - Adrenal Axis Dysregulation in Preterm Birth

Open Date: 2020-08-24

Close Date: 2022-07-31

Grant: Close

Triggers of Abruptio Placentae - A Case Crossover Study of an Ischemic Placental

Open Date: 2010-09-10

Close Date: 2017-07-31

Grant: Close

A Cohort Study of Preterm Delivery in Relation to Partner Abuse, Mood and Anxiety

Open Date: 2010-09-01

Close Date: 2017-07-31

Articles (4)

Background Substance use disorders are increasingly prevalent in sub-Saharan African countries, with evident bidirectional risk for people with severe mental illness (SMI) resulting in more severe and chronic courses. This study examines the association between common substance use, including khat and alcohol, and SMI, comparing affected individuals to age and sex-matched controls in Ethiopia. Method This study uses data collected as part of the NeuroGAP-Psychosis project, a large multi-country case-control genetics study. This case-control study consisted of 6,500 people with severe mental illness and age and sex-matched 6,500 controls in Ethiopia. Current substance use was defined as any use within the last three months, while current regular use was defined as at least weekly use within the previous three months. Descriptive statistics were used to determine the demographic distribution of participants, and logistic regression was used to estimate the association between substance use and severe mental illness. Results Most cases were men (65.8%; n = 4,276) with a mean age of 36.9 (SD = 10.3) years, while the controls were 64.7% (n = 4,204) men with a mean age of 36.2 (SD = 10.9) years. Current use of tobacco, alcohol, khat, and cannabis was 15.1%, 17.2%, 20.4% and 1.0% among cases and 6.0%, 41.5%, 12.5%, and 0.8% among controls, respectively. The adjusted odds of regular tobacco and khat use were 4.8 (95% CI: 4.0, 5.9) and 1.6 (95% CI: 1.4, 1.8) times higher in cases than in controls, respectively. However, regular use of alcohol was 0.1 (95% CI: 0.1, 0.2) times lower among cases than among controls. Conclusions Tobacco and khat use were higher among cases than controls, while alcohol and cannabis use were more prevalent in controls. The high prevalence of khat use is particularly problematic in people with SMI as it adversely affects the course and outcome of mental illness. Tobacco smoking also contributes to physical health morbidity and associated premature mortality. Therefore, evidence-based screening and treatment services are warranted to mitigate the harmful health outcomes of khat use and tobacco consumption among individuals with SMI.

Year:

2025

Background: A substantial portion of the genetic predisposition for breast cancer is explained by multiple common genetic variants of relatively small effect. A subset of these variants, which have been identified mostly in individuals of European (EUR) and Asian ancestries, have been combined to construct a polygenic risk score (PRS) to predict breast cancer risk, but the prediction accuracy of existing PRSs in Hispanic/Latinx individuals (H/L) remain relatively low. We assessed the performance of several existing PRS panels with and without addition of H/L-specific variants among self-reported H/L women. Methods: PRS performance was evaluated using multivariable logistic regression and the area under the ROC curve. Results: Both EUR and Asian PRSs performed worse in H/L samples compared with original reports. The best EUR PRS performed better than the best Asian PRS in pooled H/L samples. EUR PRSs had decreased performance with increasing Indigenous American (IA) ancestry, while Asian PRSs had increased performance with increasing IA ancestry. The addition of two H/L SNPs increased performance for all PRSs, most notably in the samples with high IA ancestry, and did not impact the performance of PRSs in individuals with lower IA ancestry. Conclusions: A single PRS that incorporates risk variants relevant to the multiple ancestral components of individuals from Latin America, instead of a set of ancestry-specific panels, could be used in clinical practice. Impact: The results highlight the importance of population-specific discovery and suggest a straightforward approach to integrate ancestry-specific variants into PRSs for clinical application.

Year:

2025

Adverse life events and chronic psychological distress before and during pregnancy have frequently been associated with preterm birth but the biological underpinnings remain unclear. We investigated the association between corticosteroid levels in pre-pregnancy and first-trimester hair and the risk of preterm birth. We followed N = 1,807 pregnant women from a prospective pre-birth cohort study in Lima, Perú. Hair samples were taken at the end of the first pregnancy trimester. The two most proximal 3 cm segments to the scalp (representing pre-pregnancy and first-trimester) were analyzed to obtain hair cortisol and cortisone concentrations (HCC and HCNC). Preterm birth was defined as birth < 37 completed gestational weeks. We constructed four generalized propensity scores for pre-pregnancy and first-trimester HCC and HCNC to create corresponding inverse probability weights before fitting marginal structural models for estimating the effect of HCC and HCNC on preterm birth risk. Pre-pregnancy Log HCC was not independently associated with preterm birth risk (RR = 0.97; 95%CI: 0.79, 1.19), nor was pre-pregnancy Log HCNC (RR = 0.84; 95%CI: 0.58, 1.20). In the first trimester, a one SD increase in Log HCC was associated with a 37% increased risk of preterm birth (95%CI: 1.11, 1.69), whereas Log HCNC was not significantly associated with preterm birth risk (RR = 1.20; 95%CI: 0.87, 1.65). Our findings show that chronic corticosteroid levels in early pregnancy are causally linked to preterm birth risk in pregnant Peruvian women. This finding contributes to understanding the biological underpinnings of preterm birth better to enhance its prevention.

Year:

2024

We deployed the Blended Genome Exome (BGE), a DNA library blending approach that generates low pass whole genome (1-4x mean depth) and deep whole exome (30-40x mean depth) data in a single sequencing run. This technology is cost-effective, empowers most genomic discoveries possible with deep whole genome sequencing, and provides an unbiased method to capture the diversity of common SNP variation across the globe. To evaluate this new technology at scale, we applied BGE to sequence >53,000 samples from the Populations Underrepresented in Mental Illness Associations Studies (PUMAS) Project, which included participants across African, African American, and Latin American populations. We evaluated the accuracy of BGE imputed genotypes against raw genotype calls from the Illumina Global Screening Array. All PUMAS cohorts had R 2 concordance ≥95% among SNPs with MAF≥1%, and never fell below ≥90% R 2 for SNPs with MAF<1%. Furthermore, concordance rates among local ancestries within two recently admixed cohorts were consistent among SNPs with MAF≥1%, with only minor deviations in SNPs with MAF<1%. We also benchmarked the discovery capacity of BGE to access protein-coding copy number variants (CNVs) against deep whole genome data, finding that deletions and duplications spanning at least 3 exons had a positive predicted value of ∼90%. Our results demonstrate BGE scalability and efficacy in capturing SNPs, indels, and CNVs in the human genome at 28% of the cost of deep whole-genome sequencing. BGE is poised to enhance access to genomic testing and empower genomic discoveries, particularly in underrepresented populations.

Year:

2024

Collaborators (25)

Christopher A. Haiman

University of Southern California

UNITED STATES
View details

Laura Fejerman

Professor

University of California, Davis

UNITED STATES
View details

Serghei Mangul

University of Southern California

UNITED STATES
View details

FEI CHEN

Assistant Professor

University of Southern California

UNITED STATES
View details

Alicia Martin

Assistant Professor

Massachusetts General Hospital

UNITED STATES
View details

Michele Pato

Associate Dean for Academic Scholarship; Associate Chair for Education and Faculty Development; Della Martin Chair, Professor of Psychiatry; Clinical Director of Center for Genomic Psychiatry

Rutgers University

UNITED STATES
View details

Roel A. Ophoff

Professor

University of California, Los Angeles

UNITED STATES
View details

Charles Newton

University of Oxford

UNITED KINGDOM
View details

Weang Kee Ho

Professor

Sunway University

MALAYSIA
View details

Benjamin Neale

Associate Professor

Broad Institute

UNITED STATES
View details

Lori Chibnik

Massachusetts General Hospital

UNITED STATES
View details

Tim B. Bigdeli

SUNY Downstate Health Sciences University

UNITED STATES
View details

Toni Boltz

Massachusetts General Hospital

UNITED STATES
View details

Elad Ziv

Professor

University of California

UNITED STATES
View details

Sarah Medland

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Esther John

Professor

Stanford University School of Medicine

UNITED STATES
View details

David Whiteman

Deputy Director

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Elizabeth Atkinson

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Simone Rubinacci

FIMM/EMBL Group Leader in Statistical Genomics

University of Helsinki

FINLAND
View details

Luis G Carvajal‐Carmona

Professor

University of California, Davis

UNITED STATES
View details

Michael Talkowski

Professor

Massachusetts General Hospital

UNITED STATES
View details

David Conti

Professor

Colorado School of Public Health

UNITED STATES
View details

Michelle Williams

Professor of Epidemiology

Stanford University

UNITED STATES
View details

Dan Stein

Professor and Chair of Psychiatry

University of Cape Town

SOUTH AFRICA
View details

Kai Yuan

Assistant Professor

Indiana University School of Medicine

UNITED STATES
View details